The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
Published: | Updated:
Oral peptide pills are reshaping psoriasis care, from semaglutide breakthroughs to IL‑23 blocker icotrokinra—here's what dermatologists need to know now.
Sarita Pattisam
Advertisement
Sarita Pattisam is a third-year osteopathic medical student at the Ohio University Heritage College of Osteopathic Medicine in Dublin, Ohio.
Articles by Sarita Pattisam
Oral peptide drugs move beyond injections, bringing targeted psoriasis therapy like icotrokinra and reshaping dermatology’s treatment options.
The on-demand format of podcasts allows learners at all levels to engage with expert insights conveniently.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Dermatology Times
1
Hair Transplantation Expands Beyond the Scalp: Eyebrows, Beard, and Beyond
2
FDA Approves Brepocitinib for Dermatomyositis
3
QRX003 Meets Primary Endpoint in Netherton Syndrome Trial
4
The Aesthetic Edge: August 2026
5